ArticleBMC medicine2021
Deep learning-based six-type classifier for lung cancer and mimics from histopathological whole slide images: a retrospective study.
Article in BMC medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
61 citing papers in PubMed.
- Artificial intelligence for lung cancer classification in cytology specimens: A systematic review and diagnostic test accuracy meta-analysis of benign-malignant diagnosis and ADC/SCC/SCLC subtyping.Journal of pathology informatics · 2026Review
- Two-Step Ensemble Convolutional Neural Networks for Colonoscopic Biopsy Classification Resembling Pathologists' Process.Journal of Korean medical science · 2026Article
- Artificial Intelligence Tools in Precision Lung Cancer Care: From Early Detection to Clinical Decision Support.Cancers · 2026Review
- Improving MRI-based differentiation of brain metastasis, glioblastoma, and primary CNS lymphoma using deep learning.Neuroradiology · 2026Article
- LungDxFormer: a transformer-CNN hybrid model with dynamic spatial attention for accurate lung cancer detection and classification.Scientific reports · 2026Article
- CLWD: a Chinese histopathology dataset for lung adenocarcinoma subtype classification.Scientific data · 2026Article
- Graph Neural Network-Based Multi-Scale Whole Slide Image Fusion for pT Staging of Muscle-Invasive Bladder Cancer.Cancer science · 2026Article
- LungGANDetectAI: a GAN-augmented and attention-guided deep learning framework for accurate and explainable lung cancer detection.Scientific reports · 2026Article
- Article
- Article
- Superior transplant recipient outcome prediction and pathology assessment using rapid deep learning applied to procurement kidney biopsies.Scientific reports · 2025Article
- Machine Learning Models Using General and Tissue-Specific Feature Extractors for Accurate Subtyping of Biopsy Samples: Advancing Lung Cancer Diagnosis in Latin America.JTO clinical and research reports · 2025Article
- Simultaneous classification and delineation of seven types of histological growth patterns in lung adenocarcinomas using self-supervised learning and online hard patch mining.Quantitative imaging in medicine and surgery · 2025Article
- The Rise of AI-Assisted Diagnosis: Will Pathologists Be Partners or Bystanders?Diagnostics (Basel, Switzerland) · 2025Review
- Deep learning enhances precision diagnosis and treatment of non-small cell lung cancer: future prospects.Translational lung cancer research · 2025Review
- Systematic scoping review of external validation studies of AI pathology models for lung cancer diagnosis.NPJ precision oncology · 2025Article
- Evaluating the robustness of deep learning models trained to diagnose idiopathic pulmonary fibrosis using a retrospective study.Medical physics · 2025Article
- Review
- Diagnosis of Lung Cancer Using Endobronchial Ultrasonography Image Based on Multi-Scale Image and Multi-Feature Fusion Framework.Tomography (Ann Arbor, Mich.) · 2025Article
- Externally validated and clinically useful machine learning algorithms to support patient-related decision-making in oncology: a scoping review.BMC medical research methodology · 2025Article
1 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTargeted therapy and immunotherapy put forward higher demands for accurate lung cancer classification, as well as benign versus malignant disease discrimination. Digital whole slide images (WSIs) witnessed the transition from traditional histopathology to computational approaches, arousing a hype of deep learning methods for histopathological analysis. We aimed at exploring the potential of deep learning models in the identification of lung cancer subtypes and cancer mimics from WSIs.
methodsWe initially obtained 741 WSIs from the First Affiliated Hospital of Sun Yat-sen University (SYSUFH) for the deep learning model development, optimization, and verification. Additional 318 WSIs from SYSUFH, 212 from Shenzhen People's Hospital, and 422 from The Cancer Genome Atlas were further collected for multi-centre verification. EfficientNet-B5- and ResNet-50-based deep learning methods were developed and compared using the metrics of recall, precision, F1-score, and areas under the curve (AUCs). A threshold-based tumour-first aggregation approach was proposed and implemented for the label inferencing of WSIs with complex tissue components. Four pathologists of different levels from SYSUFH reviewed all the testing slides blindly, and the diagnosing results were used for quantitative comparisons with the best performing deep learning model.
resultsWe developed the first deep learning-based six-type classifier for histopathological WSI classification of lung adenocarcinoma, lung squamous cell carcinoma, small cell lung carcinoma, pulmonary tuberculosis, organizing pneumonia, and normal lung. The EfficientNet-B5-based model outperformed ResNet-50 and was selected as the backbone in the classifier. Tested on 1067 slides from four cohorts of different medical centres, AUCs of 0.970, 0.918, 0.963, and 0.978 were achieved, respectively. The classifier achieved high consistence to the ground truth and attending pathologists with high intraclass correlation coefficients over 0.873.
conclusionsMulti-cohort testing demonstrated our six-type classifier achieved consistent and comparable performance to experienced pathologists and gained advantages over other existing computational methods. The visualization of prediction heatmap improved the model interpretability intuitively. The classifier with the threshold-based tumour-first label inferencing method exhibited excellent accuracy and feasibility in classifying lung cancers and confused nonneoplastic tissues, indicating that deep learning can resolve complex multi-class tissue classification that conforms to real-world histopathological scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.